therapy ReceivesAction approved by the fda
Typicality: 0.423
Saliency: 0.405

Facets 3
as ipilimumab 5 other
recently 4 temporal
in december 4 temporal
Open triples 2
therapy → be approved by → the fda 24
therapy → be approved by → the food and drug administration 6
Sentiment analysis
negative neutral positive
0.061 0.535 0.404
Other statistics
Raw frequency 30
Normalized frequency 0.405
Modifier score 0.500
Perplexity 28.972